AbbVie Reports Second-Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
AbbVie (ABBV) Tops Q2 EPS by 15c, Issues Combined Company Guidance
July 31, 2020 7:45 AM EDTAbbVie (NYSE: ABBV) reported Q2 EPS of $2.34, $0.15 better than the analyst estimate of $2.19. Revenue for the quarter came in at $10.43 billion versus the consensus estimate of $10.08 billion.
Full-Year 2020 Outlook:
AbbVie previously issued standalone GAAP diluted EPS guidance for the full-year... More
